- $2.11bn
- $1.69bn
- $1.12bn
US FDA advisers to weigh updating 2026-27 COVID vaccines for XFG variant (updated)
US FDA advisers to weigh updating 2026-27 COVID vaccines to target XFG variant
Brief: Coatue Management Cuts Share Stake in Tesla by 96.4%, SEC filing shows
Brief: Shah Capital Management Will Vote ‘No' Across Five Proposals On Novavax's June 18 Ballot - SEC Filing
Moderna climbs for second straight session
Moderna climbs for second straight session
Moderna set to climb for second straight session
U.S. STOCKS ON THE MOVE-Instacart, New York Times, Novavax
U.S. STOCKS ON THE MOVE-DaVita, Knight-Swift, Madrigal Pharma
Novavax climbs on quarterly revenue beat
U.S. STOCKS ON THE MOVE-Walt Disney, CVS, Uber
Novavax climbs on quarterly revenue beat
Novavax beats first-quarter revenue estimates on strength in vaccine deals (updated)
Novavax beats first-quarter revenue estimates on vaccine deals strength
US CDC will not publish report showing COVID vaccine benefits, Washington Post reports (updated)
US CDC will not publish report showing COVID vaccine benefits, Washington Post reports
US CDC delays publishing report showing COVID vaccine benefits, WaPo reports
U.S. STOCKS ON THE MOVE-Meta, Legence, Chegg
U.S. STOCKS ON THE MOVE-Hims & Hers, Chewy, Longeveron